European Journal of Medicinal Chemistry p. 339 - 350 (2018)
Update date:2022-08-17
Topics:
Tian, Ye
Liu, Zhaoqiang
Liu, Jinghan
Huang, Boshi
Kang, Dongwei
Zhang, Heng
De Clercq, Erik
Daelemans, Dirk
Pannecouque, Christophe
Lee, Kuo-Hsiung
Chen, Chin-Ho
Zhan, Peng
Liu, Xinyong
Inspired by our previous efforts on the modifications of diarylpyrimidines as HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTI) and reported crystallography study, novel diarylnicotinamide derivatives were designed with a “triazole tail” occupying the entrance channel in the NNRTI binding pocket of the reverse transcriptase to afford additional interactions. The newly designed compounds were then synthesized and evaluated for their anti-HIV activities in MT-4 cells. All the compounds showed excellent to good activity against wild-type HIV-1 strain with EC50 of 0.02–1.77 μM. Evaluations of selected compounds against more drug-resistant strains showed these compounds had advantage of inhibiting E138K mutant virus which is a key drug-resistant mutant to the new generation of NNRTIs. Among this series, propionitrile (3b2, EC50(IIIB) = 0.020 μM, EC50(E138K) = 0.015 μM, CC50 = 40.15 μM), pyrrolidin-1-ylmethanone (3b8, EC50(IIIB) = 0.020 μM, EC50(E138K) = 0.014 μM, CC50 = 58.09 μM) and morpholinomethanone (3b9, EC50(IIIB) = 0.020 μM, EC50(E138K) = 0.027 μM, CC50 = 180.90 μM) derivatives are the three most promising compounds which are equally potent to the marketed drug Etravirine against E138K mutant strain but with much lower cytotoxicity. Furthermore, detailed SAR, inhibitory activity against RT and docking study of the representative compounds are also discussed.
View MoreHaiNan Periwinkle Pharmaceutical Co.,Ltd.
website:http://www.cchpharm.com/en/index.html
Contact:020-82208978
Address:Gongye road,Wuzhishan city,HaiNan province
Shenyang NovPharm Technology Co., Ltd.
Contact:.+86-24-24165786
Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.
Hunan Haili Chemical Industry Co.,Ltd.
Contact:+86-731-85521860
Address:No.251, 2nd Section, Furong Road, Changsha,Hunan,China
Contact:+86-18653358619
Address:zibo
Contact:+49-9398-993127
Address:Untertorstr. 27
Doi:10.1007/BF00923105
()Doi:10.1021/jo1020294
(2011)Doi:10.1002/jps.2600840916
(1995)Doi:10.1002/(SICI)1521-3773(19981204)37:22<3144::AID-ANIE3144>3.0.CO;2-Y
(1998)Doi:10.21577/0103-5053.20160326
(2017)Doi:10.1002/jps.2600681011
(1979)